Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

about

A simulation study to assess the potential impact of developing normal tissue complication probability models with accumulated dose Hyperfractionated abdominal reirradiation for gastrointestinal malignancies

P2860

Q58131352-B8C6EFD7-0209-416C-8F59-EC802058CBBD Q58797528-D598F95E-DC3F-4132-B6A2-4746D9240468

P2860

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

Item

http://www.wikidata.org/entity/Q36397239

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@ast

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@en

type

Item

label

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@ast

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@en

prefLabel

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@ast

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@en

P1476

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

@en

P2093

Marianne Aznar

http://www.w3.org/2001/XMLSchema#string

Mike Partridge

http://www.w3.org/2001/XMLSchema#string

Somnath Mukherjee

http://www.w3.org/2001/XMLSchema#string

P2860

Late gastrointestinal tissue effects after hypofractionated radiation therapy of the pancreas

Consolidating duodenal and small bowel toxicity data via isoeffective dose calculations based on compiled clinical data.

Lyman-Kutcher-Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data.

A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.

Fitting of normal tissue tolerance data to an analytic function.

Radiation dose-volume effects in the stomach and small bowel.

Upper abdominal normal organ contouring guidelines and atlas: a Radiation Therapy Oncology Group consensus.

A prospective study of differences in duodenum compared to remaining small bowel motion between radiation treatments: implications for radiation dose escalation in carcinoma of the pancreas

Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial.

ARCII: A phase II trial of the HIV protease inhibitor Nelfinavir in combination with chemoradiation for locally advanced inoperable pancreatic cancer.

P304

431-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RADONC.2017.04.024

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Maria A. Hawkins

Daniel Holyoake

P577

2017-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28600084

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

histogram

P932

5486774

http://www.w3.org/2001/XMLSchema#string

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

about

P2860

P2860

Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932